Women's views on human papillomavirus self-sampling: Focus groups to assess acceptability, invitation letters and a test kit in the Australian setting

Sexual Health

Volumn 12, Issue 4, 2015, Pages 279-286

  Sultana, Farhana ^a   Mullins, Robyn ^b   Murphy, Michael ^c   English, Dallas R ^a,b   Simpson, Julie A ^a   Drennan, Kelly T ^d,h   Heley, Stella ^d   Wrede, C David ^e,f   Brotherton, Julia M L ^a,d,g   Saville, Marion ^d   Gertig, Dorota M ^a,d,h  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c Michael Murphy Research   (Australia)

^d VCS Inc   (Australia)

^e ROYAL WOMEN'S HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g VICTORIAN CYTOLOGY SERVICE   (Australia)

^h Victorian Cervical Cytology Registry Melbourne   (Australia)

Author keywords

communication materials; information needs; under screened

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIAN; COST; DECISION MAKING; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; PAP SCREENING SYSTEM; PAPANICOLAOU TEST; QUALITATIVE RESEARCH; SCREENING; SELF EVALUATION; WART VIRUS; WOMEN'S HEALTH;

EID: 84938686414     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH14236     Document Type: Article

References (37)

1. Bos AB, Rebolj M, Habbema JD, van Ballegooijen M. Non-attendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006; 119: 2372-5. doi: 10.1002/ijc.22114
2. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 1996; 73: 1001-5. doi: 10.1038/bjc.1996.196
3. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen 2009; 16: 193-8. doi: 10.1258/jms.2009.009069
4. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009; 16: 199-204. doi: 10.1258/jms.2009.009073
5. Oscarsson MG, Benzein EG, Wijma BE. Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol 2008; 29: 23-31. doi: 10.1080/01674.820701504619
6. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VMJ, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao F-H, Hillemanns P, Anttila A. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014; 15: 172-83. doi: 10.1016/S1470-2045(13)70570-9
7. Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, Heid P, Davies P, Piana L. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013; 133: 2681-7
8. Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer 2011; 105: 337-9. doi: 10.1038/bjc.2011.236
9. Virtanen A, Nieminen P, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011; 20: 1960-9. doi: 10.1158/1055-9965.EPI-11-030710
10. Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2011; 128: 2681-7. doi: 10.1002/ijc.25581
11. Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, Lyons D, Walker J, Christison J, Frater A, Waller J. HPV self-sampling as an alternative strategy in non-attenders for cervical screening -a randomised controlled trial. Br J Cancer 2011; 104: 915-20. doi: 10.1038/bjc.2011.48
12. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011; 378: 1868-73. doi: 10.1016/S0140-6736(11)61522-5
13. Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of selfsampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011; 104: 248-54. doi: 10.1038/sj.bjc.6606040
14. Bais AG, van Kemenade FJ, Berkhof J, Verheijen RHM, Snijders PFJ, Voorhorst F, Babovis M, van BallegooijenM, Helmerhorst TJM, Meijer CJLM. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120: 1505-10. doi: 10.1002/ijc.22484
15. Gok M, van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JML, Belien JAM, Babovic M, Snijders PJF, Meijer CJLM. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer 2012; 130: 1128-35. doi: 10.1002/ijc.26128
16. Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann Oncol 2004; 15: 863-9. doi: 10.1093/annonc/mdh240
17. Pengsaa P, Vatanasapt V, Sriamporn S, Sanchaisuriya P, Schelp FP, Noda S, Kato S, Kongdee W, Kanchanawirojkul N, Aranyasen O. A self-administered device for cervical cancer screening in northeast Thailand. Acta Cytol 1997; 41: 749-54. doi: 10.1159/000332698
18. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed-biologic concordance and womens preferences. Am J Obstet Gynecol 2002; 186: 365-73. doi: 10.1067/mob.2002.121076
19. Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002; 11: 265-75. doi: 10.1089/152460902753668466
20. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC Jr. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health 2005; 14: 721-8. doi: 10.1089/jwh.2005.14.721
21. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, Wardle J. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006; 13: 208-13
22. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006; 82: 337-9. doi: 10.1136/sti.2005.019430
23. Khanna N, Mishra SI, Tian G, Tan MT, Arnold S, Lee C, Ramachandran S, Bell L, Baquet CR, Lorincz A. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. Int J Gynecol Cancer 2007; 17: 615-22. doi: 10.1111/j.1525-1438.2006.00835.x
24. Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T, Mai V. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. J Obstet Gynaecol Can 2007; 29: 817-28
25. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, Verheijen RHM, Meijer CJLM. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002; 55: 435-9. doi: 10.1136/jcp.55.6.435
26. Forrest S, McCaffery K, Waller J, Desai M, Szarewski A, Cadman L, Wardle J. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screen 2004; 11: 85-8. doi: 10.1258/096914104774061065
27. Schmeink CE, Bekkers RL, Massuger LF, Melchers WJ. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol 2011; 21: 139-53. doi: 10.1002/rmv.686
28. Sultana F, English DR, Simpson JA, Brotherton JML, Drennan K, Mullins R, Heley S, Wrede CD, Saville M, Gertig DM. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never-and under-screened women in Australia. BMC Cancer 2014; 14: 207. doi: 10.1186/1471-2407-14-207
29. Barata PC, Mai V, Howlett R, Gagliardi AR, Stewart DE. Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention. J Psychosom Obstet Gynaecol 2008; 29: 251-7. doi: 10.1080/01674820802076038
30. Howard M, Lytwyn A, Lohfeld L, Redwood-Campbell L, Fowler N, Karwalajtys T. Barriers to acceptance of self-sampling for human papillomavirus across ethnolinguistic groups of women. Can J Public Health 2009; 100: 365-9
31. Kahn JA, Bernstein DI, Rosenthal SL, Huang B, Kollar LM, Colyer JL, Tissot AM, Hillard PA, Witte D, Groen P, Slap GB. Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect 2005; 81: 408-14. doi: 10.1136/sti.2004.012047
32. Goldsmith MR, Bankhead CR, Kehoe ST, Marsh G, Austoker J. Information and cervical screening: a qualitative study of womens awareness, understanding and information needs about HPV. J Med Screen 2007; 14: 29-33. doi: 10.1258/096914107780154459
33. McCaffery K, Irwig L. Australian womens needs and preferences for information about human papillomavirus in cervical screening. J Med Screen 2005; 12: 134-41. doi: 10.1258/0969141054855238
34. Hendry M, Pasterfield D, Lewis R, Clements A, Damery S, Neal RD, Adke R, Weller D, Campbell C, Patnick J, Sasieni P, Hurt C, Wilson S, Wilkinson C. Are women ready for the new cervical screening protocol in England?. A systematic review and qualitative synthesis of views about human papillomavirus testing. Br J Cancer 2012; 107: 243-54. doi: 10.1038/bjc.2012.256
35. Kwan TT, Cheung AN, Lo SS, Lee PWH, Tam KF, Chan KKL, Ngan HYS. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study. Acta Obstet Gynecol Scand 2011; 90: 445-51. doi: 10.1111/j.1600-0412.2011.01092.x
36. Papa D, Moore Simas TA, Reynolds M, Melnitsky H. Assessing the role of education in womens knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening. J Low Genit Tract Dis 2009; 13: 66-71. doi: 10.1097/LGT.0b013 e31818a53f0
37. National Cervical Screening Program. National cervical screening program renewal. Canberra: Department of Health and Ageing, Australian Government; 2013